Nektar Therapeutics Eulerpool Ziņas

Nektar Therapeutics Eulerpool News

Nektar Therapeutics Akciju Ziņas

Nektar Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Nektar Therapeutics ziņas mēs apkopojam šeit.

• 1. novembris ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amidst Mixed Financials
• 31. oktobris ·

  Yahoo
  Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
• 29. oktobris ·

  Yahoo
  Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
• 29. oktobris ·

  TipRanks
  Nektar’s rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• 29. oktobris ·

  Thefly.com
  Nektar's rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• 28. oktobris ·

  GuruFocus
  Nektar Therapeutics (NKTR) Shares Surge Amidst Moderate Biotech Sector Gains
• 17. oktobris ·

  Yahoo
  Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
• 17. oktobris ·

  Thefly.com
  Nektar says published Phase 1 NKTR-25 data show favorable efficacy
• 17. oktobris ·

  Seeking Alpha
  Nektar sees promising phase 1 results of NKTR-255 in B-cell lymphoblastic leukemia
• 4. oktobris ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amid Market Fluctuations